PMID- 40970761
OWN - NLM
STAT- Publisher
LR  - 20250919
IS  - 2159-8290 (Electronic)
IS  - 2159-8274 (Linking)
DP  - 2025 Sep 19
TI  - Activation of T cell-intrinsic p53 by acetylation elicits antitumor immunity to 
      boost cancer immunotherapy.
LID - 10.1158/2159-8290.CD-25-0649 [doi]
AB  - Although p53 plays a central role in tumor suppression, how it is regulated in T 
      cells to exert antitumor effects remains unclear. Here, we show that activation 
      of T cell-intrinsic p53 via carboxyl-terminal domain (CTD) acetylation during 
      immunotherapy activates the IFN-γ pathway, promotes CD8+ T cell infiltration, and 
      elicits CD8+ T cell-dependent antitumor immunity. Using T cell-specific knockin 
      mouse models, we demonstrate that loss of CTD acetylation in T cells abrogates 
      CD8+ T cell-dependent antitumor immunity whereas expression of CTD 
      acetylation-mimicking p53 in T cells enhances this immune response. Moreover, we 
      identify IFNG as a direct target of T cell-intrinsic p53 and uncover a positive 
      feedback loop between p53 and the IFN-γ pathway for enhancing T cell-dependent 
      antitumor immunity. Our study reveals that CTD acetylation-mediated activation of 
      T cell-intrinsic p53 promotes antitumor immunity in response to immunotherapy, 
      highlighting a non-tumor cell-autonomous mechanism of p53 action by regulating 
      adoptive immune responses.
FAU - Yan, Xiaojun
AU  - Yan X
AUID- ORCID: 0000-0002-0827-7499
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Xu, Wenbin
AU  - Xu W
AUID- ORCID: 0000-0003-4862-0498
AD  - Changping Laboratory, Beijing, China.
FAU - Yao, Han
AU  - Yao H
AUID- ORCID: 0000-0002-3409-8136
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Wu, Zhen
AU  - Wu Z
AUID- ORCID: 0000-0002-6730-1225
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Ning, Jingyuan
AU  - Ning J
AUID- ORCID: 0000-0002-9842-1684
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Zhao, Shidong
AU  - Zhao S
AUID- ORCID: 0000-0002-7823-8217
AD  - Peking University People's Hospital, Beijing, Beijing, China.
FAU - Liu, Yajing
AU  - Liu Y
AUID- ORCID: 0000-0001-5757-2518
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Zhang, Meng
AU  - Zhang M
AUID- ORCID: 0009-0004-5279-5164
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Xu, Dongkui
AU  - Xu D
AUID- ORCID: 0000-0003-0605-8273
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
FAU - Shen, Zhanlong
AU  - Shen Z
AUID- ORCID: 0000-0002-6897-5125
AD  - Peking University People's Hospital, Beijing, Beijing, China.
FAU - Gu, Wei
AU  - Gu W
AUID- ORCID: 0000-0002-1480-2368
AD  - Columbia University, New York, United States.
FAU - Wang, Donglai
AU  - Wang D
AUID- ORCID: 0000-0002-2247-1765
AD  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 
      China.
LA  - eng
PT  - Journal Article
DEP - 20250919
PL  - United States
TA  - Cancer Discov
JT  - Cancer discovery
JID - 101561693
SB  - IM
EDAT- 2025/09/19 12:50
MHDA- 2025/09/19 12:50
CRDT- 2025/09/19 09:23
PHST- 2025/09/17 00:00 [accepted]
PHST- 2025/04/13 00:00 [received]
PHST- 2025/08/06 00:00 [revised]
PHST- 2025/09/19 12:50 [medline]
PHST- 2025/09/19 12:50 [pubmed]
PHST- 2025/09/19 09:23 [entrez]
AID - 765443 [pii]
AID - 10.1158/2159-8290.CD-25-0649 [doi]
PST - aheadofprint
SO  - Cancer Discov. 2025 Sep 19. doi: 10.1158/2159-8290.CD-25-0649.
